Close Correlation of 1‐β‐D‐Arabinofuranosylcytosine 5′‐Triphosphate, an Intracellular Active Metabolite, to the Therapeutic Efficacy of N(4)‐Behenoyl‐1‐β‐D‐arabinofuranosylcytosine Therapy for Acute Myelogenous Leukemia

N(4)‐Behenoyl‐l‐β‐D‐arabinofuranosylcytosine (BHAC), a prodrug of 1‐β ‐D‐arabinofuranosylcy‐tosine, is used effectively for the treatment of leukemia in Japan. BHAC therapy may be more effective if it is delivered in conjunction with monitoring of 1‐β ‐D‐arabinofuranosylcytosine 5′‐tri‐phosphate (ar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Jpn J Cancer Res
Main Authors: Yamauchi, Takahiro, Kawai, Yasukazu, Goto, Nobuyuki, Kishi, Shinji, Imamura, Shin, Yoshida, Akira, Urasaki, Yoshimasa, Fukushima, Toshihiro, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2001
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926845/
https://ncbi.nlm.nih.gov/pubmed/11572766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2001.tb01188.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares